Overview Request Sample Pages Request Customization Download PDF
You are viewing: Latin America Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The Latin America Gastrointestinal Stent Market was valued at $39.9 Million in 2026 and projected to reach to $49.9 Million by 2031, representing a compound annual growth rate of 4.6%. Latin America's gastrointestinal stent market is poised for steady growth driven by increasing healthcare infrastructure investments and rising awareness of minimally invasive treatment options.

Latin America Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Latin America Gastrointestinal Stent Market Trends and Insights

  • Latin America's market expansion is driven by increasing prevalence of gastrointestinal disorders, rising healthcare expenditure, and growing adoption of minimally invasive procedures across the region.
  • Latin America continues to strengthen its medical device infrastructure, supporting wider accessibility to advanced stent technologies. In Latin America, the gastrointestinal stent market reflects steady demand from both urban and emerging healthcare centers.
  • Latin America's growth trajectory, though moderate compared to global benchmarks, underscores the region's developing healthcare landscape and improving patient awareness.
  • Latin America's market is characterized by a mix of established multinational players and regional manufacturers competing to capture growing procedural volumes..

Key Market Statistics

  • CAGR (2026-2031) 4.6% CAGR
  • Market Size, 2026 ~USD 39.9 Million
  • Forecast, 2031 ~USD 49.9 Million
  • Geography Latin America

Latin America Gastrointestinal Stent Market Overview

Market Size & Growth :

Latin America's gastrointestinal stent market is valued at USD 39.9 million in 2026 and is projected to reach USD 49.9 million by 2031, growing at a CAGR of 4.6%, outpacing several developed regions.

Rising GI Disorder Prevalence :

Increasing incidence of gastrointestinal disorders, including esophageal strictures, biliary obstructions, and colorectal cancers across Latin America is driving demand for effective stent interventions.

Minimally Invasive Adoption :

Growing preference for minimally invasive endoscopic procedures in Latin American healthcare systems is accelerating stent adoption as a safer, cost-effective alternative to traditional surgical interventions.

Healthcare Investment Expansion :

Rising healthcare expenditure and improved access to advanced medical technologies in major Latin American economies are creating favorable conditions for market penetration and product innovation.

Latin America Gastrointestinal Stent Market Dynamics

  • The region's expanding middle class and improving reimbursement policies are facilitating greater adoption of advanced stent technologies across both urban and emerging healthcare centers. Key growth drivers include the rising burden of gastrointestinal diseases, aging populations, and healthcare provider initiatives to adopt endoscopic interventions.
  • Brazil and Mexico lead regional demand, while emerging markets present untapped opportunities.
  • Market players are focusing on localized distribution networks and cost-effective solutions to capture market share in this growing segment..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Latin America's gastrointestinal stent market is valued at USD 39.9 million in 2026 and will reach USD 49.9 million by 2031.
    • Latin America is experiencing a 4.6% CAGR, reflecting steady but moderate growth driven by healthcare infrastructure improvements.
    • Latin America's market growth is supported by rising gastrointestinal disease prevalence and increased adoption of minimally invasive procedures.
    • Latin America's competitive landscape includes both multinational and regional manufacturers targeting expanding procedural volumes.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    Latin America Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    Target Audience

    • Medical Device Manufacturers : Stent manufacturers need Latin America market data to develop region-specific product portfolios, establish distribution partnerships, and identify pricing strategies aligned with local healthcare economics.
    • Healthcare Providers & Hospitals : Hospital networks and gastroenterology centers require market insights to benchmark procurement costs, evaluate supplier options, and plan capital investments in endoscopic equipment and stent inventory.
    • Investment & Private Equity Firms : Investors targeting Latin American healthcare need comprehensive market sizing and growth forecasts to evaluate acquisition targets, assess portfolio company performance, and identify expansion opportunities.
    • Healthcare Consultants & Advisors : Consulting firms advising healthcare clients require detailed Latin America market data to support strategic planning, market entry analysis, and competitive positioning recommendations.
    • Regulatory & Government Bodies : Healthcare policymakers and regulatory agencies use market data to inform reimbursement policies, healthcare infrastructure planning, and technology adoption initiatives across Latin American nations.

    Key Companies in the Latin America Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Latin America vs. other regions

    HowLatin America compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 318.6 Million · 5.5% wtd CAGR ·
    Europe
    ~USD 218.3 Million · 5.2% wtd CAGR ·
    Asia Pacific
    ~USD 207.9 Million · 7.1% wtd CAGR ·
    Middle East & Africa
    ~USD 21.9 Million · 3.1% wtd CAGR ·

    Countries within Latin America - compare and drill down

    Country2025 size (native)
    BrazilUSD 23.66 Million
    MexicoUSD 12.05 Million
    ArgentinaUSD 6.46 Million

    Country market size visualization

    Brazil
    USD 23.66 Million
    Mexico
    USD 12.05 Million
    Argentina
    USD 6.46 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into Latin America's gastrointestinal stent market with country-level breakdowns for Brazil, Mexico, and Argentina, enabling targeted market entry and expansion strategies.
    • Growth Opportunity Identification : Identify high-growth segments and emerging opportunities within Latin America's 4.6% CAGR market, with forecasts through 2031 to support long-term business planning and investment decisions.
    • Competitive Landscape Analysis : Understand regional competitive dynamics, market consolidation trends, and key player strategies specific to Latin American healthcare systems and regulatory environments.
    • Healthcare Trend Insights : Access data on minimally invasive procedure adoption rates, reimbursement policies, and healthcare infrastructure development across Latin American countries to inform product positioning.
    • Risk & Opportunity Assessment : Evaluate market risks, regulatory challenges, and growth catalysts specific to Latin America to optimize resource allocation and mitigate market entry barriers.

    Frequently asked questions

    What is the current size of the gastrointestinal stent market in Latin America?

    In Latin America, the gastrointestinal stent market is estimated at USD 39.9 million in 2026.

    What is the projected market size for gastrointestinal stents in Latin America by 2031?

    Latin America's gastrointestinal stent market is forecast to reach USD 49.9 million by 2031.

    What is the CAGR for the gastrointestinal stent market in Latin America?

    Latin America's gastrointestinal stent market is projected to grow at a CAGR of 4.6% from 2026 to 2031.

    What factors are driving growth in Latin America's gastrointestinal stent market?

    Latin America's market growth is driven by increasing gastrointestinal disease prevalence, rising healthcare expenditure, improved medical device infrastructure, and growing adoption of minimally invasive procedures.

    Who are the key players in Latin America's gastrointestinal stent market?

    Latin America's gastrointestinal stent market includes both established multinational medical device manufacturers and regional competitors vying for market share.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status